Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced that Christy Shafer has been appointed Chief Commercial Officer, reporting to Scott Braunstein, M.D., Chief Executive Officer of Marinus. “As we continue to build our senior team with formidable leaders, we believe Christy is the right person to
November 9, 2020
· 5 min read